Canada markets open in 2 hours 1 minute

Brooklyn ImmunoTherapeutics, Inc. (BTX)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
0.5495-0.0039 (-0.70%)
At close: 04:00PM EDT
0.5650 +0.02 (+2.82%)
After hours: 07:24PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 31.79M
Enterprise Value 17.53M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)4.89
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -0.14

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3-96.77%
S&P500 52-Week Change 3-11.60%
52 Week High 318.7500
52 Week Low 30.4600
50-Day Moving Average 30.7868
200-Day Moving Average 34.0722

Share Statistics

Avg Vol (3 month) 3611.54k
Avg Vol (10 day) 3935.74k
Shares Outstanding 557.45M
Implied Shares Outstanding 6N/A
Float 831.57M
% Held by Insiders 143.34%
% Held by Institutions 132.92%
Shares Short (May 30, 2022) 43.46M
Short Ratio (May 30, 2022) 45.61
Short % of Float (May 30, 2022) 46.71%
Short % of Shares Outstanding (May 30, 2022) 46.02%
Shares Short (prior month Apr 28, 2022) 42.79M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:2
Last Split Date 3Mar 25, 2021

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2021
Most Recent Quarter (mrq)Dec 30, 2021

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-74.20%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -27.31M
Net Income Avi to Common (ttm)-122.32M
Diluted EPS (ttm)-2.8250
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)16.98M
Total Cash Per Share (mrq)0.3
Total Debt (mrq)2.72M
Total Debt/Equity (mrq)41.88
Current Ratio (mrq)5.10
Book Value Per Share (mrq)0.12

Cash Flow Statement

Operating Cash Flow (ttm)-23.49M
Levered Free Cash Flow (ttm)-12.4M